★★★★★
Average rating on the App Store. Apple doesn't publish how many ratings each star has.
This app isn't in any of our charts yet.
Pricing now displays correctly in your local currency. Various improvements and fixes for a smoother experience.
Antihypertensives — complete prescribing reference for antihypertensive drug classes, based on NICE NG136 and ESC/ESH 2023 guidelines. FREE TO TRY — no purchase needed: - ACE Inhibitors — ramipril, lisinopril, perindopril, doses, monitoring, side effects - Calcium Channel Blockers — amlodipine, felodipine, diltiazem, mechanism FULL ACCESS — £9.99 one-time purchase: Unlocks all sections including: - Angiotensin Receptor Blockers — losartan, candesartan, telmisartan - Beta-Blockers — bisoprolol, carvedilol, labetalol, heart failure and AF - Diuretics — indapamide, spironolactone, furosemide, thiazide-like - Other Agents — doxazosin, hydralazine, methyldopa, alpha-blockers - Compelling Indications — drug choice by comorbidity, diabetes, CKD, HF, AF, stroke, pregnancy - Resistant Hypertension — step 4 agents, spironolactone, renal denervation - References — NICE NG136, ESC/ESH 2023, landmark trials, all tappable One-time purchase. No subscription. Works fully offline. For qualified healthcare professionals only. Always verify doses against current BNF before prescribing.